Intacare improves outcomes transparency and the assessment of benefit in pharma and med-tech innovation.

Intacare PIE produces timely and relevant patient outcomes insights, enabling patient-reported outcomes and late effects prediction and monitoring to ensure the true benefit of medical innovation can be showcased, both in the short and long-term.

By leveraging whole population data or insights derived from the broader Intacare knowledge pool, an improved view of innovation benefit can be established. This enables both researchers and innovators to undertake a more powerful multidimensional analysis of trial or onco-med-tech benefits and highlight these to clinicians and payers.